Clinical Trial Update: A Study of the Efficacy and Safety of Desloratadine (MK-4117) in Japanese Participants With Perennial Allergic Rhinitis (MK-4117-200) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of desloratadine (MK-4117) in Japanese participants with perennial allergic rhinitis has completed, and results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perennial Allergic Rhinitis

Drugs mentioned

• Desloratadine (desloratadine)

Snippet

Sponsor: Organon and Co | Conditions: Perennial Allergic Rhinitis | Phase 3 | Status: COMPLETED | Results posted: 2014-08-15